Congressional Stock Trades & Disclosures
John Hoeven is a U.S. Senator, a Republican representing ND. As of February 2020, Bullish Whales has tracked 229 disclosed stock trades across 104 companies, representing $23.5M in disclosed transaction value, each filed publicly under the STOCK Act.
About Hoeven's congressional trading
Hoeven's disclosed activity shows a buy-leaning pattern, with 158 purchases and 67 sales (a buy-to-sell ratio of 2.36). Hoeven has traded IVZ, WTW, and T most frequently among disclosed positions.
On the Bullish Whales Score, which ranks members of Congress by how worth-following their disclosed buys have been relative to peers, Hoeven rates 69 out of 100, a Solid reading. The score weights a member's realized track record (80%) and conviction in repeat positions (20%); it is a descriptive research signal drawn from public filings, not investment advice.
Hoeven's most recent disclosed trade was a purchase of BlackRock Health Sciences Trust II (BMEZ) from January 2020. Each trade below links to its filing, an estimated price range, and post-trade performance versus the market.
Trading activity
Disclosed trades & legislation
| Company | Type | Size | Traded | Est. price | Change |
|---|---|---|---|---|---|
 BMEZBlackRock Health Sciences Trust II | Buy | $100,001 - $250,000 | 29 JAN 2020 | N/A | — |
 MPCMarathon Petroleum Corp | Buy | $50,001 - $100,000 | 31 DEC 2019 | N/A | — |
| MPCMarathon Petroleum Corp | Buy | $50,001 - $100,000 | 31 DEC 2019 | N/A | — |
 VFIJXVFIJX | Buy | $50,001 - $100,000 | 31 DEC 2019 | N/A | — |
 SLBSchlumberger NV | Buy | $50,001 - $100,000 | 31 DEC 2019 | N/A | — |
 BIVBIV | Buy | $100,001 - $250,000 | 31 DEC 2019 | N/A | — |
 REZIResideo Technologies Inc | Sell | $1,001 - $15,000 | 23 DEC 2019 | N/A | — |
 TGBAXTGBAX | Sell | $100,001 - $250,000 | 23 DEC 2019 | N/A | — |
| TGBAXTGBAX | Sell | $100,001 - $250,000 | 23 DEC 2019 | N/A | — |
 GTXGarrett Motion Inc | Sell | $1,001 - $15,000 | 23 DEC 2019 | N/A | — |
Congressional trading news
The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.
John Hoeven congressional trading FAQ
Can John Hoeven legally trade stocks?
Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Bullish Whales compiles John Hoeven's disclosures so the public can review them.
Where does Bullish Whales get John Hoeven's trading data?
Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.
How can I track John Hoeven's stock trades?
Bullish Whales tracks every stock trade John Hoeven discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.
How many stock trades has John Hoeven disclosed?
Bullish Whales has tracked 229 disclosed trades by John Hoeven across 104 companies.
Which stocks does John Hoeven trade most?
John Hoeven's most frequently disclosed positions include IVZ, WTW, T, DWDP, and IBM. The full list of companies and individual filings is shown on this page.
What was John Hoeven's most recent stock trade?
John Hoeven most recently bought BlackRock Health Sciences Trust II (BMEZ) in January 2020, according to public STOCK Act filings tracked by Bullish Whales.
What is John Hoeven's Bullish Whales Score?
John Hoeven has a Bullish Whales Score of 69 out of 100 (Solid). The score ranks members by how worth-following their disclosed buys have been, weighting realized track record (80%) and conviction (20%). It is a descriptive research signal, not investment advice.
Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.